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a Ruptured Abdominal Aortic Aneurysm: A Systematic Review and
Meta-analysis of Short-term Survival
van Beek S.C., Conijn A.P., Koelemay M.J., Balm R. Eur J Vasc Endovasc
Surg 2014;47:593-602.
Background: There is clinical equipoise between open (OR) and
endovascular aneurysm repair (EVAR) for the best treatment of ruptured
abdominal aortic aneurysm (RAAA).
Objective: The aim of the study was to perform a systematic review and
meta-analysis to estimate the short-term (combined 30-day or in-hospital)
survival after EVAR and OR for patients with RAAA. Data sources included
Medline, Embase, and the World Health Organization International Clinical
Trials Registry until 13 January 2014. All randomised controlled trials
(RCTs), observational cohort studies, and administrative registries
comparing OR and EVAR of at least 50 patients were included. Articles
were full-length and in English.
Methods: Standard PRISMA guidelines were followed. The method-
ological quality of RCTs was assessed with the Cochrane Collaboration's
tool for assessing risk of bias. The quality of observational studies was
assessed with a modiﬁed Cochrane Collaboration's tool for assessing risk
of bias, the NewcastleeOttawa Scale, and the Methodological Index for
Non-Randomized Studies. The results of the RCTs, of the obersvational
studies, and of the administrative registries were pooled separately and ana-
lysed with the use of a random effects model.
Results: From a total of 3,769 articles, three RCTs, 21 observational
studies, and eight administrative registries met the inclusion criteria. In the
RCTs, the risk of bias was lowest and the pooled odds ratio for death after
EVAR versus OR was 0.90 (95% CI 0.65-1.24). The majority of the obser-
vational studies had a high risk of bias and the pooled odds ratio for death
was 0.44 (95% CI 0.37-0.53). The majority of the administrative registries
had a high risk of bias and the pooled odds ratio for death was 0.54 (95% CI
0.47-0.62).
Conclusion: Endovascular aneurysm repair is not inferior to open
repair in patients with a ruptured abdominal aortic aneurysm. This supports
the use of EVAR in suitable patients and OR as a reasonable alternative.
Endoscopic Vein Harvesting in Lower Extremity Arterial Bypass: A
Systematic Review
Jauhari Y.A., Hughes C.O., Black S.A., Jones K.G., Hinchliffe R.J.,
Thompson M.M., Holt P.J., Karthikesalingam A. Eur J Vasc Endovasc
Surg 2014;47:621-39.
Objective: Endoscopic vein harvesting (EVH) for arterial bypass sur-
gery may be associated with lower wound complication rates than open vein
harvesting (OVH), but other long-term outcomes remain controversial, and
there are concerns that graft patency may be poorer after EVH compared
with OVH. We conducted a systematic review of all available evidence for
EVH in lower extremity arterial bypass (LEAB).
Methods: A literature search of Medline, Embase, Ovid and Cochrane
databases between 1996 and 2013 was performed using the terms “endo-
scopic vein harvesting”, “minimally invasive vein harvest”, “peripheral bypass
surgery”, and “lower extremity bypass surgery”, and detailed in line with the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Pri-
mary outcomes were graft patency and overall wound complication rates.
Secondary outcomes were wound infection, length of hospital stay, and
cost-effectiveness. Summary estimates were calculated by random effects
meta-analysis if sufﬁcient data were available.
Results: We identiﬁed 18 cohort studies and case series, with consid-
erable clinical heterogeneity, including 2,343 patients. Meta-analysis of six
studies revealed a signiﬁcantly reduced rate of primary patency after EVH
(hazard ratio 1.29, 95% conﬁdence interval [CI] 1.03-1.63), with no signif-
icant difference between EVH and OVH with respect to wound infection in
12 studies (odds ratio 0.81, 95% CI 0.61-1.08). There was a lack of strong
evidence to support the secondary outcomes of EVH.
Conclusion: EVH reduces primary patency rates after LEAB, but
does not demonstrate an advantage with respect to postoperative wound1750complications. However, the available data are heterogeneous, and uncer-
tainty is introduced by both evolution in technology and increasing tech-
nical experience. EVH should be used with caution and in the context of
formal research.
Role of Calcifying Nanoparticle in the Development of Hyperplasia
and Vascular Calciﬁcation in an Animal Model
Cenizo Revuelta N., Gonzalez-Fajardo J.A., Bratos M.A., Alvarez-Gago T.,
Aguirre B., Vaquero C. Eur J Vasc Endovasc Surg 2014;47:640-6.
Objective: Calcifying nanoparticles (NPs) have been detected recently
in calciﬁed human arterial specimens and are involved in the process of calci-
ﬁcation. This study was designed to test the hypothesis that human-derived
NPs could worsen the response to arterial endothelial injury and induce
vascular calciﬁcation.
Methods: The right carotid artery of 24 New Zealand rabbits was
injured with an angioplasty balloon. Animals were perfused intravenously
with saline (100 mL) during the experiment and divided into three groups:
group-A, control; group-B, exposed to NPs (2 mL) obtained from calciﬁed
aortic valves; and group-C, exposed to NPs (2 mL) and treated postopera-
tively with atorvastatin (2.5 mg/kg/24 h). At 30 days, both carotid arteries
were removed and examined histologically. Blood measurements were
monitored during the study.
Results: The intimal hyperplasia area was signiﬁcantly larger in the
injured right carotid artery compared with the left unoperated carotid artery
in all groups. There was no signiﬁcant variation in medial area between
groups. Morphometrically, the intima/media ratio (IMR) was signiﬁcantly
higher in damaged carotids compared with controls. A signiﬁcant increase
of IMR was found in group-B (1.81 6 0.41) compared with group-A
(0.38 6 0.59; P = .004) or group-C (0.89 6 0.79; P = .035). Differences
between groups C and A were not signiﬁcant (P = .064). Calciﬁcations were
observed in six animals, all of which had been exposed to NPs (4 in group-
B, 2 in group-C, P = .027). Plasma levels of cholesterol and triglycerides
remained stable.
Conclusions: This research conﬁrms the ability of systemic inocula-
tion of human-derived NPs to accelerate hyperplasia and stimulate calciﬁca-
tion in localized areas of arteries previously submitted to endothelial
damage, while it was harmless in healthy arteries. Atorvastatin was demon-
strated to slow down this process.
Hyperbaric Oxygen for the Treatment of Diabetic Foot Ulcers: A
Systematic Review
Stoekenbroek R.M., Santema T.B., Legemate D.A., Ubbink D.T., van den
Brink A., Koelemay M.J.W. Eur J Vasc Endovasc Surg 2014;47:647-55.
Objective: A systematic review of randomized clinical trials (RCTs) to
assess the additional value of hyperbaric oxygen therapy (HBOT) in pro-
moting the healing of diabetic foot ulcers and preventing amputations
was performed.
Methods: MEDLINE, Embase, and the Cochrane Library were
searched to identify RCTs in patients with diabetic foot ulcers published
up to August 2013. Eligible studies reported the effectiveness of adjunctive
HBOT with regard to wound healing, amputations, and additional
interventions.
Results: Seven of the 669 identiﬁed articles met the inclusion criteria,
comprising 376 patients. Three trials included 182 patients with ischaemic
ulcers, two trials studied 64 patients with non-ischaemic ulcers, and two
trials comprising 130 patients did not specify ulcer type. Two trials were
of good methodological quality. Pooling of data was deemed inappropriate
because of heterogeneity. Two RCTs in patients with ischaemic ulcers
found increased rates of complete healing at 1-year follow-up (number
needed to treat (NNT) 1.8 (95% CI: 1.1 to 4.6) and 4.1 (95% CI: 2.3 to
19)), but found no difference in amputation rates. A third trial in ischaemic
ulcers found signiﬁcantly lower major amputation rates in patients with
HBOT (NNT 4.2, 95% CI: 2.4 to 17), but did not report on wound heal-
ing. None of the RCTs in non-ischaemic ulcers reported differences in
